A novel byproduct compound having the following chemical formula B:

##STR00001##

wherein R is hydrogen or CH.sub.3; a composition including an admixture of: (A) a product having the following chemical formula A:

##STR00002##

wherein R is hydrogen or CH.sub.3; and (B) the above novel byproduct compound having the chemical formula B; and a composition including a reaction product of: (a) an aromatic epoxy resin; (b) hydrogen; (c) a catalyst; and (d) a solvent; wherein the reaction product produced is a cycloaliphatic epoxy resin admixture of the combination of (i) the above product having the chemical formula A and (ii) the novel byproduct compound having the chemical formula B; wherein the above product having the chemical formula A includes at least a cis-cis isomer, a cis-trans isomer, and a trans-trans isomer; and the novel byproduct compound having the chemical formula B includes at least a cis isomer and a trans isomer.

A novel byproduct compound having the following chemical formula B:

##STR00001##

wherein R is hydrogen or CH.sub.3; a composition including an admixture of: (A) a product having the following chemical formula A:

##STR00002##

wherein R is hydrogen or CH.sub.3; and (B) the above novel byproduct compound having the chemical formula B; and a composition including a reaction product of: (a) an aromatic epoxy resin; (b) hydrogen; (c) a catalyst; and (d) a solvent; wherein the reaction product produced is a cycloaliphatic epoxy resin admixture of the combination of (i) the above product having the chemical formula A and (ii) the novel byproduct compound having the chemical formula B; wherein the above product having the chemical formula A includes at least a cis-cis isomer, a cis-trans isomer, and a trans-trans isomer; and the novel byproduct compound having the chemical formula B includes at least a cis isomer and a trans isomer.

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

##STR00001##

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

##STR00001##

The invention provides oxaspiro[2.5]octane derivatives and analogs, methods for preparation thereof, intermediates thereto, pharmaceutical compositions, and uses thereof in the treatment of various disorders and conditions, such as overweight and obesity.

The invention provides oxaspiro[2.5]octane derivatives and analogs, methods for preparation thereof, intermediates thereto, pharmaceutical compositions, and uses thereof in the treatment of various disorders and conditions, such as overweight and obesity.

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.

The present invention relates to a nebivolol synthesis method and intermediate compound thereof. Specifically, the present invention relates to a method for synthesizing nebivolol, intermediate compound thereof, and a method for preparing the intermediate compound.

The present invention relates to a nebivolol synthesis method and intermediate compound thereof. Specifically, the present invention relates to a method for synthesizing nebivolol, intermediate compound thereof, and a method for preparing the intermediate compound.